Completed NCT00305565
This summary needs review. Please check the official study record and contact the research team for details.
In United States Why is this study shown? This study is directly about Depression.
Depression Behavioral Over 18 Years
Countries United States
Sponsor Cyberonics, Inc.
Condition Depression Terminated NCT05551195
This study was terminated in the United States. It is testing digital Therapeutic for depression.
In United States Why is this study shown? This study is directly about Depression.
Depression Device i A study involving a tool, app, wearable, test, or medical device. From 22 Years to 45 Years
Countries United States
Sponsor Woebot Health
Condition Depression Completed NCT03460756
This study exists to understand whether the medication Oral is both safe enough and useful enough to take further. For people living with Depression, that matters because care needs to work in daily life, not just in theory.
In United States Why is this study shown? This study is directly about Depression.
Depression Drug i A study involving a medication or substance. From 18 Years to 48 Years
Countries United States
Sponsor Marinus Pharmaceuticals
Condition Depression Completed NCT05550532
This study is completed in the United States, in France, in Canada, .... It is testing Aticaprant 10 Milligrams (mg) for Depression.
In United States Why is this study shown? This study is directly about Depression.
Depression Drug From 18 Years to 74 Years
Countries United States, France, Canada, ...
Sponsor Janssen Research & Development, LLC
Condition Depression Completed NCT06057012
This study is completed in the United States. It is testing BRII-296 for depression.
In United States Why is this study shown? This study is directly about Depression.
Depression Drug From 18 Years to 45 Years
Countries United States
Sponsor Brii Biosciences Limited
Condition Depression Terminated NCT00637494
This study was terminated in the United States. It is testing mifepristone for depression.
In United States Why is this study shown? This study is directly about Depression.
Depression, Schizophrenia Behavioral Over 22 Years
Countries United States
Sponsor Corcept Therapeutics
Condition Depression, Schizophrenia Completed NCT06285916
This study is completed in the United States. It is testing Efficacy, Safety, and Tolerability of Oral NORA520 for depression.
In United States Why is this study shown? This study is directly about Depression.
Depression Drug From 18 Years to 45 Years
Countries United States
Sponsor DuKang Pharmaceuticals, Inc.
Condition Depression Completed NCT02942004
This study is completed in the United States. It is testing SAGE-547 for depression.
In United States Why is this study shown? This study is directly about Depression.
Depression Drug From 18 Years to 45 Years
Countries United States
Sponsor Supernus Pharmaceuticals, Inc.
Condition Depression Completed NCT02942017
This study is completed in the United States. It is testing Safety and Efficacy of SAGE-547 for depression.
In United States Why is this study shown? This study is directly about Depression.
Depression Drug From 18 Years to 45 Years
Countries United States
Sponsor Supernus Pharmaceuticals, Inc.
Condition Depression Completed NCT02614547
This study is completed in the United States. It is testing SAGE-547 for depression.
In United States Why is this study shown? This study is directly about Depression.
Depression Drug From 18 Years to 45 Years
Countries United States
Sponsor Supernus Pharmaceuticals, Inc.
Condition Depression Completed NCT06117397
This study exists to see whether a guided support group is workable and worth testing more broadly. Researchers are trying to understand whether a guided support group can give earlier or clearer feedback during care.
Remote / online Why is this study shown? This study is directly about Depression.
Depression Other From 16 Years to 45 Years
Countries United States
Sponsor University of Massachusetts, Worcester
Condition Depression Completed NCT00208156
This summary needs review. Please check the official study record and contact the research team for details.
In United States Why is this study shown? This study is directly about Depression.
Depression, Schizophrenia Drug From 18 Years to 75 Years
Countries United States
Sponsor Corcept Therapeutics
Condition Depression, Schizophrenia